A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Thomas Jefferson University
Intensity Therapeutics, Inc.
City of Hope Medical Center
Novartis
Basilea Pharmaceutica
Big Ten Cancer Research Consortium
Alliance for Clinical Trials in Oncology
University Medical Centre Ljubljana
M.D. Anderson Cancer Center
Eli Lilly and Company
University of Texas Southwestern Medical Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
MediGene
Massachusetts General Hospital
Loma Linda University